WG
MED icon

Winton Group’s Medifast MED Stock Holding History

Winton Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,496
Closed -$977K – 673
2024
Q1 		$977K Buy
25,496
+19,351
+315% +$937K 0.07% 274
2023
Q4 		$413K Buy
6,145
+1,243
+25% +$86.6K 0.03% 412
2023
Q3 		$367K Sell
4,902
-2,336
-32% -$207K 0.03% 467
2023
Q2 		$667K Sell
7,238
-5,772
-44% -$514K 0.06% 232
2023
Q1 		$1.35M Buy
13,010
+1,534
+13% +$170K 0.08% 338
2022
Q4 		$1.32M Buy
11,476
+530
+5% +$61.7K 0.09% 328
2022
Q3 		$1.19M Buy
10,946
+4,178
+62% +$599K 0.08% 351
2022
Q2 		$1.22M Sell
6,768
-199
-3% -$35.6K 0.06% 419
2022
Q1 		$1.19M Buy
6,967
+1,011
+17% +$191K 0.06% 411
2021
Q4 		$1.25M Buy
5,956
+273
+5% +$56.4K 0.08% 387
2021
Q3 		$1.09M Buy
5,683
+74
+1% +$18.2K 0.06% 457
2021
Q2 		$1.59M Sell
5,609
-2,359
-30% -$639K 0.09% 281
2021
Q1 		$1.69M Sell
7,968
-3,875
-33% -$927K 0.1% 200
2020
Q4 		$2.33M Sell
11,843
-19,852
-63% -$3.51M 0.17% 72
2020
Q3 		$5.21M Sell
31,695
-10,512
-25% -$1.73M 0.17% 113
2020
Q2 		$5.86M Sell
42,207
-18,986
-31% -$1.74M 0.15% 158
2020
Q1 		$3.83M Sell
61,193
-1,536
-2% -$140K 0.1% 350
2019
Q4 		$6.87M Sell
62,729
-26,706
-30% -$2.58M 0.1% 362
2019
Q3 		$9.27M Buy
89,435
+21,681
+32% +$2.33M 0.11% 223
2019
Q2 		$8.69M Sell
67,754
-51,719
-43% -$7.18M 0.17% 183
2019
Q1 		$15.2M Buy
119,473
+100,776
+539% +$12.8M 0.31% 123
2018
Q4 		$2.34M Sell
18,697
-80,218
-81% -$13.7M 0.05% 292
2018
Q3 		$21.9M Buy
98,915
+2,105
+2% +$427K 0.46% 47
2018
Q2 		$15.5M Buy
96,810
+4,826
+5% +$617K 0.4% 61
2018
Q1 		$8.6M Buy
91,984
+7,363
+9% +$550K 0.24% 105
2017
Q4 		$5.91M Buy
+84,621
New +$5.61M 0.17% 195

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Winton Group's MED Position: Q2 2024 in Review

Winton Group sold out of Medifast (MED) in Q2 2024, closing a stake of 25,496 shares — an estimated $977K sold.

Winton Group first reported a position in MED in Q4 2017 and held it in 26 quarters. The position peaked at $21.9M in Q3 2018. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Winton Group reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Winton Group sold 25,496 Medifast shares in Q2 2024, an estimated $977K.
  • Winton Group first reported a position in Medifast in Q4 2017 and held it in 26 quarters.
  • Winton Group's Medifast position peaked at $21.9M in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Winton Group's 13F filing for Q2 2024, filed 9 Aug 2024.